GSK begins cancer cell therapy tie-up with Immatics

Cancer biotech Immatics has begun a collaboration with GlaxoSmithKline to develop novel therapies built around its T-cell-based technology.

ALX Oncology cancer drug claims two FDA fast-track reviews

Blockbusters in waiting: drug launches to watch in 2020

FDA sets August action date for Seattle’s oral HER2 drug tuc...

Seattle Genetics says data backs Padcev combo for first-line...

Xtandi takes fight to prostate cancer rivals with survival d...